Results 51 to 60 of about 6,503 (137)
Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology
Theresa Mallick-Searle,1 Brett Snodgrass,2 Jeannine M Brant,3 1Pain Management Center, Stanford Health Care, Redwood City, CA, 2LifeLinc Pain Centers, Cordova, TN, 3Billings Clinic, Billings, MT, USA Abstract: Herpes zoster, also known as shingles, is a ...
Mallick-Searle T, Snodgrass B, Brant JM
doaj
Reports on surgical treatment for postherpetic trigeminal neuralgia after COVID vaccination have not been found in the literature. Here, we described a case of postherpetic trigeminal neuralgia after COVID vaccination that was treated with percutaneous ...
M. Kodeeswaran +6 more
doaj +1 more source
Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment
Chronic pain arises through distinct molecular pathways categorized into nociceptive, neuropathic, and nociplastic types. Nociceptive pain begins with TRP channel activation in peripheral nociceptors, signaling via Aδ‐ and C‐fibers through the spinal dorsal horn and spinothalamic tracts to the brain, regulated by descending inhibition and involving ...
Xiaofeng Dai +3 more
wiley +1 more source
Navigating the Ethereal Tightrope: The Nanogenerator Manipulates Neurons for Immune Equilibrium
This review explores how nanogenerators modulate neuroimmune responses, offering innovative strategies for treating neurological disorders. By interfacing with neural pathways, they enable precise control of immune activity, especially via vagus nerve stimulation.
Jia Du +5 more
wiley +1 more source
Aims Crisugabalin is a novel calcium channel α2δ subunit ligand and a highly selective oral gamma‐aminobutyric acid (GABA) analogue developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN). This study investigated pharmacokinetic properties and safety of crisugabalin in subjects with renal impairment ...
Shibeilei Lin +6 more
wiley +1 more source
To investigate the ability of the 35 kDa low-molecular-weight hyaluronan fragment (HA35) to relieve neuropathic and inflammatory pain, including postherpetic neuralgia and shoulder, neck, back and temporomandibular pain.
FengHe Xu +9 more
doaj +1 more source
BACKGROUND AND OBJECTIVES: Post-herpetic neuralgia is defined as pain persisting for more than three months after the resolution of skin eruptions observed in herpes-zoster.
Charles Amaral de Oliveira +2 more
doaj +1 more source
Sequential Varicella and Herpes Zoster in an Immunocompetent Adult
ABSTRACT Varicella and herpes zoster, caused by primary infection and reactivation of varicella‐zoster virus (VZV) respectively, can present with a wide spectrum of cutaneous and systemic complications. This case highlights an uncommon sequential presentation of varicella and zoster in an immunocompetent adult in noncontiguous dermatomes and emphasizes
Bibek Sharma, Supriya Paudel
wiley +1 more source
Spinal Cord Stimulation in Refractory Postherpetic Neuralgia in Portugal: A Case Report
Postherpetic neuralgia is one of the most severe complications after herpes zoster infection. Patients who experience persistent pain despite conservative treatment may benefit from interventional therapies, such as spinal cord stimulation.
Ana Inês Silva +4 more
doaj +1 more source
Mengzhen Xu,1 Jin Liu,1 Hui Zhang,2 Ruiting Li,3 Junni Wei1 1School of Public Health, Shanxi Medical University, Taiyuan, People’s Republic of China; 2Department of Pain Management, First Hospital of Shanxi Medical University, Taiyuan, People’s Republic ...
Xu M, Liu J, Zhang H, Li R, Wei J
doaj

